FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091750 [Registered on: 25/07/2025] Trial Registered Prospectively
Last Modified On: 24/07/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Treatment for repeated mouth ulcers with mouth opening difficulty. 
Scientific Title of Study   Randomized Controlled clinical study of MARCEL poly herbal oral rinse in management of Oral Sub Mucous Fibrosis. 
Trial Acronym  MARCEL 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nisar Ali Khan  
Designation  Professor 
Affiliation  Govt Ayurved College and Hospital Nanded 
Address  Govt Ayurved College and Hospital Vazirabad Nanded

Nanded
MAHARASHTRA
431601
India 
Phone  9325607099  
Fax    
Email  dr.khan_na@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pratibha Kondibarao Waghmare 
Designation  Ph D scholar Assistant Professor  
Affiliation  Govt Ayurved College and Hospital Nanded  
Address  Govt Ayurved College and Hospital Vazirabad Nanded

Nanded
MAHARASHTRA
431601
India 
Phone  9503779408  
Fax    
Email  pratibhawaghmare94@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pratibha Kondibarao Waghmare 
Designation  Ph D scholar Assistant Professor  
Affiliation  Govt Ayurved College and Hospital Nanded  
Address  Govt Ayurved College and Hospital Vazirabad Nanded

Nanded
MAHARASHTRA
431601
India 
Phone  9503779408  
Fax    
Email  pratibhawaghmare94@gmail.com  
 
Source of Monetary or Material Support  
Jansuta Pharmaceuticals N-1201 Iscon Platinum Bopal circle Bopal Ahmedabad Gujrat India Pin 380058  
 
Primary Sponsor  
Name  Jansuta Pharmaceuticals  
Address  N 1201 Iscon platinum Bopal circle Bopal Ahmedabad 380058 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nisar Ali Khan   OPD No 24 Shalakya Tantra Department Govt Ayurved College and Hospital   Vazirabad Nanded 431601
Nanded
MAHARASHTRA 
9325607099

dr.khan_na@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Govt Ayurved College Nanded   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K121||Other forms of stomatitis. Ayurveda Condition: MUKHAROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-40 KavalaH (Procedure Reference: b Shaman or Prasadan KavalaH, Procedure details: 10 drops of MARCEL polyherbal oral rinse in 160 ml of Lukewarm water for gargling for 20 t30 seconds twice or thrice a day)
(1) Medicine Name: MARCEL polyherbal oral rinse, Reference: Contains Mentha spicata Osmium sanctum Eletteria cardmoum Cinnamomum camphora, Route: Topical, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 10(drops), Frequency: tds, Duration: 60 Days
2Comparator ArmProcedure-40 KavalaH (Procedure Reference: b Shaman or Prasadan KavalaH, Procedure details: 10 drops of Irimedadi oil in 160 ml of lukewarm water for20 to 30 seconds thrice a day)
(1) Medicine Name: Irimedadi oil, Reference: Chapter 61 Mukharogadhikar Bhaishajya Ratnavali, Route: Topical, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 10(drops), Frequency: tds, Duration: 60 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients of Oral Sub Mucous fibrosis 
 
ExclusionCriteria 
Details  Extensive fibrosis with severe trismus within inter incisal distance less than 10 mm
Disease is most advanced with premalignant and malignant changes
Generalized fibromatosis
Oral manifestations of scleroderma
Oral lichen plants
Pale Oral mucosa of anaemia mimicking blanching
Chronic debilitating conditions such as TB HIV
Patient not willing to give up addiction habits of Gutka pan masala tobacco etc 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in inter incisional distance   Before Treatment 0 day
After treatment 60 th day
 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   04/08/2025 
Date of Study Completion (India) 15/05/2026 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Oral Sub Mucous Fibrosis is a common chronic stomatitis leading to trismus
It may lead to leukoplakia erythroplakia and malignant changes
Satisfactory treatment is not available 
MARCEL is poly herbal medicine to be used locally as oral rinse in diluted form
Drug is FDA approved and clinical trials are already done
Control drug Irimedadi oil is an Ayurvedic medicine for local use for chronic stomatitis
Multicentric controlled clinical trial is being conducted 

 
Close